• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Population pharmacokinetic/pharmacodynamic methodology and applications: a bibliography.

作者信息

Yuh L, Beal S, Davidian M, Harrison F, Hester A, Kowalski K, Vonesh E, Wolfinger R

机构信息

Biometrics Department, Parke-Davis Pharmaceutical Research, Ann Arbor, Michigan 48105.

出版信息

Biometrics. 1994 Jun;50(2):566-75.

PMID:8068854
Abstract

This bibliography lists all published methodological works (statistical methodology, implementation methodology, review papers, descriptions of software) in the area of population pharmacokinetics/pharmacodynamics up to 1993 and all published works describing applications of population pharmacokinetics/pharmacodynamics up to 1992.

摘要

相似文献

1
Population pharmacokinetic/pharmacodynamic methodology and applications: a bibliography.
Biometrics. 1994 Jun;50(2):566-75.
2
Bridging the gap: ageing, pharmacokinetics and pharmacodynamics.弥合差距:衰老、药代动力学与药效学
J Pharm Pharmacol. 2005 Jun;57(6):671-9. doi: 10.1211/0022357056163.
3
An implementation of the Expectation-Maximisation (EM) algorithm for population pharmacokinetic-pharmacodynamic modelling in ACSLXTREME.一种用于ACSLXTREME中群体药代动力学-药效学建模的期望最大化(EM)算法的实现。
Comput Methods Programs Biomed. 2009 Oct;96(1):49-62. doi: 10.1016/j.cmpb.2009.03.011. Epub 2009 May 1.
4
Data warehouse implementation with clinical pharmacokinetic/pharmacodynamic data.临床药代动力学/药效学数据的数据仓库实施
Int J Clin Pharmacol Ther. 2002 Mar;40(3):S14-29.
5
Pharmacokinetic-pharmacodynamic crisis in the elderly.老年人的药代动力学-药效学危机
Am J Ther. 2007 Sep-Oct;14(5):488-98. doi: 10.1097/01.mjt.0000183719.84390.4d.
6
Pharmacokinetic/pharmacodynamic modeling in drug research and development.药物研发中的药代动力学/药效学建模
J Clin Pharmacol. 2000 Dec;40(12 Pt 2):1399-418.
7
Pk-fit: a pharmacokinetic/pharmacodynamic and statistical data analysis software.Pk-fit:一款药代动力学/药效学及统计数据分析软件。
Comput Biomed Res. 2000 Oct;33(5):315-29. doi: 10.1006/cbmr.2000.1548.
8
Quantitative pharmacology or pharmacokinetic pharmacodynamic integration should be a vital component in integrative pharmacology.定量药理学或药代动力学-药效学整合应成为整合药理学的重要组成部分。
J Pharmacol Exp Ther. 2009 Dec;331(3):767-74. doi: 10.1124/jpet.109.157172. Epub 2009 Sep 24.
9
Assessing pharmacokinetic and pharmacodynamic interactions in clinical trials of antiepileptic drugs.评估抗癫痫药物临床试验中的药代动力学和药效学相互作用。
Adv Neurol. 1998;76:95-103.
10
Gender differences in pharmacokinetics and pharmacodynamics.药代动力学和药效学中的性别差异。
Int J Clin Pharmacol Ther. 1999 Nov;37(11):529-47.

引用本文的文献

1
PBPK Modeling to Simulate the Fate of Compounds in Living Organisms.基于生理的药代动力学模型模拟化合物在生物体内的命运。
Methods Mol Biol. 2022;2425:29-56. doi: 10.1007/978-1-0716-1960-5_2.
2
Absence of P-glycoprotein transport in the pharmacokinetics and toxicity of the herbicide paraquat.百草枯的药代动力学和毒性中不存在 P-糖蛋白转运。
J Pharmacol Exp Ther. 2014 Feb;348(2):336-45. doi: 10.1124/jpet.113.209791. Epub 2013 Dec 2.
3
Rapid sample size calculations for a defined likelihood ratio test-based power in mixed-effects models.
基于似然比检验的混合效应模型中特定功效的快速样本量计算。
AAPS J. 2012 Jun;14(2):176-86. doi: 10.1208/s12248-012-9327-8. Epub 2012 Feb 17.
4
Estimation of binding rate constants using a simultaneous mixed-effects method: application to monoamine transporter reuptake inhibitor reboxetine.使用同时混合效应方法估计结合率常数:在单胺转运体再摄取抑制剂瑞波西汀中的应用。
Br J Pharmacol. 2010 May;160(2):389-98. doi: 10.1111/j.1476-5381.2010.00719.x.
5
How many subjects are necessary for population pharmacokinetic experiments? Confidence interval approach.群体药代动力学实验需要多少受试者?置信区间法。
Eur J Clin Pharmacol. 2008 Jul;64(7):705-13. doi: 10.1007/s00228-008-0493-7. Epub 2008 May 16.
6
Integrated pharmacokinetics and pharmacodynamics in drug development.药物研发中的整合药代动力学与药效学
Clin Pharmacokinet. 2007;46(9):713-37. doi: 10.2165/00003088-200746090-00001.
7
Optimal design for multiresponse pharmacokinetic-pharmacodynamic models - dealing with unbalanced designs.多响应药代动力学-药效学模型的优化设计——处理非平衡设计
J Pharmacokinet Pharmacodyn. 2007 Jun;34(3):313-31. doi: 10.1007/s10928-006-9048-7. Epub 2007 Feb 7.
8
Pharmacokinetic-pharmacodynamic modelling: history and perspectives.药代动力学-药效学建模:历史与展望
J Pharmacokinet Pharmacodyn. 2006 Jun;33(3):227-79. doi: 10.1007/s10928-005-9002-0. Epub 2006 Jan 11.
9
Pharmacokinetic/pharmacodynamic modelling of GnRH antagonist degarelix: a comparison of the non-linear mixed-effects programs NONMEM and NLME.促性腺激素释放激素拮抗剂地加瑞克的药代动力学/药效学建模:非线性混合效应程序NONMEM和NLME的比较。
J Pharmacokinet Pharmacodyn. 2004 Dec;31(6):441-61. doi: 10.1007/s10928-005-5911-1.
10
Physiologically based modelling of inhibition of metabolism and assessment of the relative potency of drug and metabolite: dextromethorphan vs. dextrorphan using quinidine inhibition.基于生理学的代谢抑制建模以及药物和代谢物相对效力评估:使用奎尼丁抑制作用研究右美沙芬与右啡烷
Br J Clin Pharmacol. 2003 Jul;56(1):57-67. doi: 10.1046/j.1365-2125.2003.01853.x.